| Mark Barbour Constantian, MD | |
|
19 Tyler St, Suite 302, Nashua, NH 03060-2951 | |
| (603) 880-7700 | |
| (603) 880-6660 |
| Full Name | Mark Barbour Constantian |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 19 Tyler St, Nashua, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184789323 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 5913 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark Barbour Constantian, MD 19 Tyler St, Suite 302, Nashua, NH 03060-2951 Ph: (603) 880-7700 | Mark Barbour Constantian, MD 19 Tyler St, Suite 302, Nashua, NH 03060-2951 Ph: (603) 880-7700 |
News Archive
New data released by the Forum of International Respiratory Societies (FIRS) to coincide with World Spirometry Day today has revealed a lack of understanding and concern among the public about the world's biggest killer - lung disease, which now claims the lives of almost 4 million people a year.
Two doctors at Haukeland University Hospital have made great progress in their work to solve chronic fatigue syndrome (CFS). Trials cancer medicine has improved the health of two out of three CFS patients.
With the aging of nearly 80 million baby boomers, Alzheimer's disease is an impending epidemic that requires a new approach to prevention as well as management of the disease, according to a UC Santa Barbara professor who has co-authored a new book on the topic.
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and ZeClinics, a contract research organization using zebrafish to carry out services focused on analyzing the safety, efficacy and biomedical relevance of new compounds, today announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics' CRISPR/Cas9 patent portfolio.
Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.
› Verified 8 days ago
Donna J. Mayo, L.P.N. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 19 Tyler St, Suite 302, Nashua, NH 03060 Phone: 603-880-7700 Fax: 603-880-6660 | |
Jeremy Waldman, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Riverside St, Suite 105, Nashua, NH 03062 Phone: 603-577-5559 Fax: 603-577-5579 |